Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
CALL
Ericsson
ERIC
$33.7B
| $378K | ﹤0.01% |
43,000
-64,600
| -60% | -$572K |
|
4452
Franklin Covey
FC
$244M
| $378K | ﹤0.01% |
11,731
+6,686
| +133% | +$242K |
|
4453
Omega Flex
OFLX
$311M
| $378K | ﹤0.01% |
3,529
+2,100
| +147% | +$205K |
|
4454
ProShares UltraPro Short S&P 500
SPXU
$391M
| $378K | ﹤0.01% |
+189
| New | +$441K |
|
4455
CALL
Tronox
TROX
$948M
| $378K | ﹤0.01% |
33,100
-100
| -0.3% | -$999 |
|
|
AHT
4456
Ashford Hospitality Trust
AHT
$20.7M
| $377K | ﹤0.01% |
135
+28
| +26% | +$78.4K |
|
|
ORC
4457
Orchid Island Capital
ORC
$1.27B
| $377K | ﹤0.01% |
12,910
+6,485
| +101% | +$186K |
|
4458
Arcus Biosciences
RCUS
$3.62B
| $376K | ﹤0.01% |
37,237
+15,024
| +68% | +$126K |
|
|
PFBI
4459
DELISTED
Premier Financial Bancorp
PFBI
| $376K | ﹤0.01% |
20,721
+4,982
| +32% | +$88.8K |
|
|
ARDC
4460
Are Dynamic Credit Allocation Fund
ARDC
$301M
| $375K | ﹤0.01% |
24,457
| – | – |
|
4461
PUT
Manulife Financial
MFC
$74.4B
| $375K | ﹤0.01% |
18,500
+11,800
| +176% | +$225K |
|
4462
Invesco Preferred ETF
PGX
$3.81B
| $375K | ﹤0.01% |
25,000
-5,000
| -17% | -$74.6K |
|
|
EIGR
4463
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $375K | ﹤0.01% |
841
+377
| +81% | +$134K |
|
4464
Calix
CALX
$2.49B
| $374K | ﹤0.01% |
46,732
+23,599
| +102% | +$176K |
|
4465
Silicon Laboratories
SLAB
$7.2B
| $374K | ﹤0.01% |
3,229
+3,145
| +3,744% | +$345K |
|
|
SWN
4466
CALL
DELISTED
Southwestern Energy Company
SWN
| $374K | ﹤0.01% |
154,600
+82,500
| +114% | +$171K |
|
4467
CALL
Keurig Dr Pepper
KDP
$42.3B
| $373K | ﹤0.01% |
12,900
-29,400
| -70% | -$844K |
|
|
RAD
4468
PUT
DELISTED
Rite Aid Corporation
RAD
| $373K | ﹤0.01% |
24,100
+12,400
| +106% | +$121K |
|
4469
Hingham Institution for Saving
HIFS
$668M
| $372K | ﹤0.01% |
1,770
+1,080
| +157% | +$208K |
|
|
PDLI
4470
DELISTED
PDL BioPharma, Inc.
PDLI
| $372K | ﹤0.01% |
114,927
-157,472
| -58% | -$457K |
|
4471
Sterling Infrastructure
STRL
$16.6B
| $370K | ﹤0.01% |
26,267
+12,922
| +97% | +$195K |
|
|
MDR
4472
PUT
DELISTED
McDermott International
MDR
| $370K | ﹤0.01% |
546,710
+148,050
| +37% | +$189K |
|
4473
Moderna
MRNA
$22.8B
| $369K | ﹤0.01% |
18,842
-9,163
| -33% | -$163K |
|
|
AGS
4474
DELISTED
PlayAGS
AGS
| $368K | ﹤0.01% |
30,307
-12,975
| -30% | -$148K |
|
4475
PUT
Sysco
SYY
$39.6B
| $368K | ﹤0.01% |
4,300
-17,200
| -80% | -$1.39M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.